CD4 and Parkinson disease: Interestingly, the increase of TMEM119-positive microglia and CD4+ cells in the MMD-LB group was similar to the PD group, suggesting that downregulation of CX3CL1 expression is a greater factor than cell loss in driving nigral neuroinflammation.